Loading asset research
PRF Technologies Ltd. Ordinary Shares
PRFXNasdaq · USD · StocksQuote as of · Exchange session not verified$0.86
-7.33%
Today
PRFX
Loading 1D prices…
Market cap
$3M
Volume
88.1K
52w high
$7.9552w low
$0.852Company profile
PRF Technologies Ltd. Ordinary Shares
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Tel Aviv, United States
Employees
6
Fiscal year end
1231
CIK
1801834
Session & valuation
Open$0.912
Previous close$0.928
Day high$0.93
Day low$0.852
30-day avg. volume294.7K
Outstanding shares830.6K
Diluted EPS-$7.47
Latest annual period
P/E (trailing)-0.12
P/E (forward)-0.07
Price / book0.08
Beta1.04
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ARTLArtelo Biosciences Inc. Common Stock | $3M | $0.00 | — | -$37.75 | -3.55% | Hold |
| SPRCSciSparc Ltd. Ordinary Shares | $3M | $856K | -1422.78% | $203.89 | +2.63% | Unrated |
| SXTP60 Degrees Pharmaceuticals Inc. Common Stock | $3.2M | $1M | -732.51% | -$11.73 | -3.23% | Hold |
| APUSApimeds Pharmaceuticals US Inc. Common Stock | $3.2M | $0.00 | — | -$0.55 | -3.00% | Unrated |
| PPBTPurple Biotech Ltd. American Depositary Shares | $2.8M | $0.00 | — | -$54.00 | -1.15% | Buy |